Preparing to monitor muscle inflammation in Duchenne muscular dystrophy
Official title: Clinical Trial Readiness for Monitoring Muscle Inflammation in Duchenne Muscular Dystrophy
Funded at State University of Ny,binghamton · NIH-10891745 · Data updated 2026-11-12
This study is looking for better ways to track muscle inflammation in people with Duchenne muscular dystrophy (DMD) so that future treatments can be tested more effectively.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | State University of Ny,binghamton NIH-funded |
| Lab location | 1 site (Binghamton, United States) |
| Project start | August 1, 2023 |
| Project end | June 30, 2026 |
| Funding year | 2024 |
| Award (this year) | $192,285 |
| NIH project number | 5R21TR004895-02 |
| Project ID | NIH-10891745 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with Duchenne muscular dystrophy, particularly those experiencing muscle inflammation.
✕Less likely to help
Patients with other forms of muscular dystrophy or those without muscle inflammation may not benefit from this research.
What this research studies
This research focuses on developing methods to effectively monitor muscle inflammation in patients with Duchenne muscular dystrophy (DMD). It aims to establish clinical trial readiness by identifying reliable biomarkers and assessment techniques that can be used in future studies. The approach involves analyzing muscle tissue and blood samples to understand the inflammatory processes associated with DMD. By enhancing the ability to track disease progression and treatment response, this research seeks to improve the design of clinical trials for new therapies.
Why it matters
Potential benefit: If successful, this research could lead to more effective monitoring and treatment strategies for patients with Duchenne muscular dystrophy.
How similar studies have gone: Other research has shown promise in using biomarkers to monitor muscle diseases, but this specific approach to DMD is relatively novel.
Where this research is happening
-
State University of Ny,binghamton
Binghamton, United States Active
Researchers
- Principal investigator: Hoffman, Eric P. — State University of Ny,binghamton
- Study coordinator: Hoffman, Eric P.
Related research
Other NIH-funded projects on the same topics.
-
Advancing manufacturing and release testing for a Duchenne gene editing therapy
A project to optimize how a dual-vector AAV gene editing treatment for Duchenne muscular dystrophy is made and tested, so it can move toward clinical use.
-
Understanding why Duchenne Muscular Dystrophy worsens and how to stop it
A research team at USC is studying Duchenne muscular dystrophy to find out why the disease continues to progress and how to interrupt harmful changes in muscle tissue.
-
Stopping steroid-related muscle and bone wasting in Duchenne muscular dystrophy
Researchers are testing ways to protect muscles and bones in people with Duchenne muscular dystrophy who take long-term steroid medicines.
-
MR clues to how nNOS affects energy use and blood flow in Becker and Duchenne muscular dystrophy
This project looks at how advanced MRI tests can track muscle energy and blood flow changes in people with Becker and Duchenne muscular dystrophy as new gene therapies are explored.
-
Digital motor-skill tracking for infants with Duchenne Muscular Dystrophy using wearables
A wearable-sensor project aims to quietly track and quantify how motor skills develop in babies and young boys with Duchenne Muscular Dystrophy.
-
Genetic factors that influence Duchenne Muscular Dystrophy progression
A study to find genes that change how severe Duchenne muscular dystrophy is in boys and young men, using patient data and DNA samples.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.